Fidelity Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102M | Sell |
|
|||||
|
2025
Q1 | $145M | Buy |
|
|||||
|
2024
Q4 | $84.6M | Sell |
|
|||||
|
2024
Q3 | $97.8M | Buy |
|
|||||
|
2024
Q2 | $72.6M | Buy |
|
|||||
|
2024
Q1 | $66.1M | Sell |
|
|||||
|
2023
Q4 | $70.2M | Sell |
|
|||||
|
2023
Q3 | $130M | Sell |
|
|||||
|
2023
Q2 | $153M | Buy |
|
|||||
|
2023
Q1 | $84.2M | Buy |
|
|||||
|
2022
Q4 | $56.6M | Buy |
|
|||||
|
2022
Q3 | $15.6M | Buy |
|
|||||
|
2022
Q2 | $9.04M | Buy |
|
|||||
|
2022
Q1 | $5.09M | Sell |
|
|||||
|
2021
Q4 | $16.2M | Buy |
|
|||||
|
2021
Q3 | $14M | Buy |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $19.1M | Buy |
|
|||||
|
2020
Q4 | $20.9M | Sell |
|
|||||
|
2020
Q3 | $34.2M | Sell |
|
|||||
|
2020
Q2 | $47.3M | Buy |
|
|||||
|
2020
Q1 | $21.3M | Buy |
|
|||||
|
2019
Q4 | $37.3M | Buy |
|
|||||
|
2019
Q3 | $2K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.44M | Sell |
|
|||||
|
2018
Q2 | $3.14M | Hold |
|
|||||
|
2018
Q1 | $2.41M | Sell |
|
|||||
|
2017
Q4 | $6.75M | Sell |
|
|||||
|
2017
Q3 | $8.41M | Sell |
|
|||||
|
2017
Q2 | $9.59M | Sell |
|
|||||
|
2017
Q1 | $7.01M | Sell |
|
|||||
|
2016
Q4 | $15.9M | Sell |
|
|||||
|
2016
Q3 | $21.1M | Hold |
|
|||||
|
2016
Q2 | $20.2M | Sell |
|
|||||
|
2016
Q1 | $24.1M | Sell |
|
|||||
|
2015
Q4 | $26.2M | Buy |
|